Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo

Kidney International

Volumn 55, Issue 6, 1999, Pages 2236-2249

  Hugo, Christian ^a,b,c,d,e,f   Pichler, Raimund P ^a,b,c,d,e,f   Schulze Lohoff, Eckhard ^a,b,c,d,e,f   Pröls, Felicitas ^a,b,c,d,e,f   Adler, Stephen ^a,b,c,d,e,f   Krutsch, Henry C ^a,b,c,d,e,f   Murphy Ullrich, Joanne E ^a,b,c,d,e,f   Couser, William G ^a,b,c,d,e,f   Roberts, David D ^a,b,c,d,e,f   Johnson, Richard J ^a,b,c,d,e,f  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e University of Alabama at Birmingham   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cell proliferation; Glomerular endothelial cells; Inflammation; Mesangial cells; Microaneurysm; Proteinuria; Thrombospondin

Indexed keywords

THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFECT; DRUG POTENCY; ENDOTHELIUM CELL; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN DETERMINATION; RAT;

EID: 0033022028     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00459.x     Document Type: Article

References (36)

1. 1. D'Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 245:709-727, 1987
2. 2. Johnson RJ: The glomerular response to injury: Progression or resolution? Kidney Int 45:1769-1782, 1994
3. 3. Iruela-Arispe L, Gordon K, Hugo C, Duijvestijn AM, Claffey KP, Reilly M, Couser WG, Alpers CE, Johnson RJ: Participation of glomerular endothelial cell in the capillary repair of glomerulonephritis. Am J Pathol 147:1715-1727, 1995
4. 4. Hugo C, Pichler R, Meek R, Gordon K, Kyriakides T, Floege J, Bornstein P, Couser WG, Johnson RJ: Thrombospondin 1 is expressed by proliferating mesangial cells in vivo and is upregulated by PDGF and bFGF. Kidney Int 48:1846-1856, 1995
5. 5. Bornstein P: Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1. J Cell Biol 130:503-506, 1995
6. 6. Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H, Hynes RO:Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia, J Clin Invest 101:982-992, 1998
7. 7. Vogel T, Guo NH, Krutzsch HC, Blake DA, Hartmann J, Mendelovitz S, Panet A, Roberts DD: Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type 1 repeats of thrombospondin. J Cell Biochem 53:74-84, 1993
8. 8. Schultz-Cherry S, Murphy-Ullrich JE: Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol 122:923-932, 1993
9. (published erratum appears in J Cell Biol 122:1143, 1993).
10. 9. Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE: Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J Biol Chem 269:26775-26782, 1994
11. 10. Schultz-Cherry S, Chen H, Mosher D, Misenheimer T, Krutzsch H, Roberts DD, Murphy-Ullrich JE: Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem 270:7304-7310, 1995
12. 11. Guo NH, Krutzsch HC, Negre E, Zabrenetzky VS, Roberts DD: Heparin-binding peptides from the type 1 repeats of thrombospondin: Structural requirements for heparin binding and promotion of melanoma cell adhesion and chemotaxis. J Biol Chem 267:19349-19355, 1992
13. 12. Sipes JM, Guo NH, Negre E, Vogel T, Krutzsch HC, Roberts DD: Inhibition of fibronectin binding and fibronectin-mediated cell adhesion to collagen by a peptide from the second type 1 repeat of thrombospondin. J Cell Biol 121:469-477, 1993
14. 13. Guo NH, Krutzsch HC, Inman JK, Shannon CS, Roberts DD: Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1. J Pept Res 50:210-221, 1997
15. 14. Roberts DD: Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J 10:1183-1191, 1996
16. 15. Adler S, Baker PJ, Johnson RJ, Ochi RF, Pritzl P, Couser WG: Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest 77:762-767, 1986
17. 16. Adler S, Eng B: Integrin receptors and function on cultured glomerular endothelial cells. Kidney Int 44:278-284, 1993
18. 17. Schulze-Lohoff E, Zanner S, Ogilvie, A, Sterzel RB: Vasoactive diadenosine polyphosphates promote growth of cultured renal mesangial cells. Hypertension 26:899-904, 1995
19. 18. Yao J, Schöcklmann HO, Pröls F, Gauer S, Sterzel RB: Exogenous nitric oxide inhibits mesangial cell adhesion to extracellular matrix components. Kidney Int 53:598-608, 1997
20. 19. Johnson RJ, Pritzl P, Iida H, Alpers CE: Platelet-complement interactions in mesangial proliferative nephritis in the rat. Am J Pathol 138:313-321, 1991
21. 20. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzl P, Gordon K, Gown AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis: Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 87:847-858, 1991
22. 21. Hugo C, Shankland SJ, Bowen-Pope DF, Couser WG, Johnson RJ: The extraglomerular origin of the mesangial cell after injury: A new role of the juxtaglomerular apparatus. J Clin Invest 100:786-794, 1997
23. 22. Duijvestijn AM, Van Goor H, Klatter F, Majoor GD, Van Bussel E, Van Breda Vriesman PJ: Antibodies defining rat endothelial cells: Reca-1, a pan-endothelial cell-specific monoclonal antibody. Lab Invest 66:459-466, 1992
24. 23. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G: A monoclonal antibody against alpha-smooth muscle actin: A new probe for smooth muscle cell differentiation. J Cell Biol 103:2787-2796, 1986
25. 24. Floege J, Eng E, Young BA, Couser WG, Johnson RJ: Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43:369-380, 1993
26. 25. Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG, Koch K, Floege J: Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 49:666-678, 1996
27. 26. Hugo C, Hugo CL, Pichler R, Gordon K, Schmidt R, Amieva M, Couser WG, Johnson RJ: The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis. J Clin Invest 97:2499-2508, 1996
28. 27. Pfeffer JM, Pfeffer MA, Fröhlich ED: Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med 78:957-962, 1971
29. 28. Floege J, Eng E, Young BA, Alpers CE, Barrett TB, Bowen-Pope DF, Johnson RJ: Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 92:2952-2962, 1993
30. 29. Iruela-Arispe L, Bornstein P, Sage H: Thrombospondin exerts an antiantiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 88:5026-5030, 1991
31. 30. Marinides GN, Suchard SJ, Mookerjee BK: Role of thrombospondin in mesangial cell growth: Possible existence of an autocrine feedback growth circuit. Kidney Int 46:350-357, 1994
32. 31. Floege J, Eng E, Lindner V, Alpers CE, Young BA, Reidy MA, Johnson RJ: Rat glomerular mesangial cells synthesize basic fibroblast growth factor: Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis. J Clin Invest 90:2362-2369, 1992
33. 32. Floege J, Burg M, Hugo C, Gordon KL, Van Goor H, Reidy M, Couser WG, Koch KM, Johnson RJ: Endogenous fibroblast growth factor-2 (FGF-2) mediates cytotoxicity in experimental mesangial proliferative glomerulonephritis. J Am Soc Nephrol 9:792-801, 1998
34. 33. Moses HL: The biological actions of transforming growth factor, in Growth Factors from Genes to Clinical Application, edited by Sara V, Hall K, Low H, New York, Raven Press, 1990, pp 141-155
35. 34. Border WA, Brees D, Noble NA: Transforming growth factor-beta and extracellular matrix deposition in the kidney. Contrib Nephrol 107:140-145, 1994
36. 35. Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 318:1657-1666, 1988